1. Up front

   Up front 23 March 2017 Pages: 763 - 765

   

2. Precision diabetes: a realistic outlook on a promising approach

   • Sally M. Marshall

   Editorial 16 March 2017 Pages: 766 - 768

3. Precision diabetes: learning from monogenic diabetes

   • Andrew T. Hattersley
   • Kashyap A. Patel

   Review Open access 17 March 2017 Pages: 769 - 777

   

4. Genetics of obesity: can an old dog teach us new tricks?

   • Giles S. H. Yeo

   Review Open access 24 December 2016 Pages: 778 - 783

   

5. Lifestyle and precision diabetes medicine: will genomics help optimise the prediction, prevention and treatment of type 2 diabetes through lifestyle therapy?

   • Paul W Franks
   • Alaitz Poveda

   Review Open access 25 January 2017 Pages: 784 - 792

   

6. Painting a new picture of personalised medicine for diabetes

   • Mark I. McCarthy

   Review Open access 07 February 2017 Pages: 793 - 799

   

7. Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?

   • Jose C. Florez

   Review 10 March 2017 Pages: 800 - 807

   

8. Chronomedicine and type 2 diabetes: shining some light on melatonin

   • Andrew C. Forrestel
   • Susanne U. Miedlich
   • Michael T. Sellix

   Review 16 December 2016 Pages: 808 - 822

   

9. The case for too little melatonin signalling in increased diabetes risk

   • Amélie Bonnefond
   • Philippe Froguel

   Commentary 17 March 2017 Pages: 823 - 825

10. Melatonin signalling and type 2 diabetes risk: too little, too much or just right?

    • Hindrik Mulder

    Commentary 16 March 2017 Pages: 826 - 829

    

11. Prolonged sitting may increase diabetes risk in physically inactive individuals: an 11 year follow-up of the HUNT Study, Norway

    • Bjørn O. Åsvold
    • Kristian Midthjell
    • Adrian Bauman

    Article 04 January 2017 Pages: 830 - 835

12. Season of birth and the risk of type 2 diabetes in adulthood: a prospective cohort study of 0.5 million Chinese adults

    • Jiahui Si
    • Canqing Yu
    • on behalf of the China Kadoorie Biobank Collaborative Group

    Article Open access 07 January 2017 Pages: 836 - 842

    

13. Serum magnesium and the risk of prediabetes: a population-based cohort study

    • Brenda C. T. Kieboom
    • Symen Ligthart
    • Ewout J. Hoorn

    Article Open access 21 February 2017 Pages: 843 - 853

    

14. Peripheral insulin resistance rather than beta cell dysfunction accounts for geographical differences in impaired fasting blood glucose among sub-Saharan African individuals: findings from the RODAM study

    • Karlijn A. C. Meeks
    • Karien Stronks
    • Charles Agyemang

    Article Open access 31 January 2017 Pages: 854 - 864

    

15. Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES

    • Jang Won Son
    • Seong Su Lee
    • Nam H. Cho

    Article 19 January 2017 Pages: 865 - 872

    

16. Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels

    • Yuvaraj Mahendran
    • Anna Jonsson
    • Torben Hansen

    Article 10 February 2017 Pages: 873 - 878

    

17. Glucose and fatty acids synergistically and reversibly promote beta cell proliferation in rats

    • Valentine S. Moullé
    • Kevin Vivot
    • Vincent Poitout

    Article 11 January 2017 Pages: 879 - 888

    

18. Hedgehog signalling in myeloid cells impacts on body weight, adipose tissue inflammation and glucose metabolism

    • Julia Braune
    • Ulrike Weyer
    • Martin Gericke

    Article 23 February 2017 Pages: 889 - 899

    

19. c-Abl inhibition mitigates diet-induced obesity through improving insulin sensitivity of subcutaneous fat in mice

    • Rong Wu
    • Jian-guang Sun
    • Zengqiang Yuan

    Article 10 January 2017 Pages: 900 - 910

    

20. Perturbations of the anti-ageing hormone Klotho in patients with type 1 diabetes and microalbuminuria

    • Giuseppe Maltese
    • Nikolaos Fountoulakis
    • Janaka Karalliedde

    Short Communication Open access 13 February 2017 Pages: 911 - 914

21. HMOX1 as a marker of iron excess-induced adipose tissue dysfunction, affecting glucose uptake and respiratory capacity in human adipocytes

    • José María Moreno-Navarrete
    • Francisco Ortega
    • José Manuel Fernández-Real

    Article 27 February 2017 Pages: 915 - 926

    

22. Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease

    • Stephen P. Gray
    • Jay C. Jha
    • Karin A. M. Jandeleit-Dahm

    Article 03 February 2017 Pages: 927 - 937

    

23. Metabolic brain adaptations to recurrent hypoglycaemia may explain the link between type 1 diabetes mellitus and epilepsy and point towards future study and treatment options

    • Domenico Tricò
    • Raimund I. Herzog

    Letter 24 February 2017 Pages: 938 - 939

24. Erratum to: Painting a new picture of personalised medicine for diabetes

    • Mark I. McCarthy

    Erratum 27 February 2017 Pages: 940 - 940